Berwyn, Pennsylvania, May 11, 2015 – Maria Maccecchini, PhD, President and CEO of QR Pharma, Inc. and Philip A. Sharp will be discussing “Secrets of a Science: Challenges and Opportunities of Biomedical Research”. The conversation will span the progress of Science from its beginnings into the future. The event is part of a Heritage Day celebration being held by the Chemical Heritage Foundation on May 14, 2015.\
Dr. Maccecchini will converse with this year’s Othmer Gold Medal recipient Dr. Phillip Sharp, Professor, Massachusetts Institute of Technology. The Othmer Gold Medal will be awarded to Dr. Sharp by the Chemical Heritage Foundation in recognition of his outstanding activity in such areas as innovation, entrepreneurship, research, education in the field of Chemistry.
Dr. Sharp is also the recipient of the 1993 Nobel Prize in Physiology or Medicine for his landmark work in the mechanisms of RNA splicing.
About QR Pharma, Inc.
Headquartered in Berwyn, Pennsylvania, QR Pharma, Inc. is a clinical-stage specialty pharmaceutical company committed to developing therapeutics with novel approaches for the treatment of cognitive impairment in neurological disorders.
QR is currently developing Posiphen as a disease modifying drug for acute as well as chronic neurodegeneration and BNC for advanced Alzheimer’s disease. For more information on QR Pharma, please visit the company’s website, www.qrpharma.com
Contact: Contact: Maria L. Maccecchini, CEO
Tel: 610 727 3710
Fax: 610 727 4001